Skip to main content

Table 1 Baseline comparison between the three groups

From: Analgesic effects of sufentanil in combination with flurbiprofen axetil and dexmedetomidine after open gastrointestinal tumor surgery: a retrospective study

 

ALL n = 640

MPCIA n = 552

OPCIA n = 48

PCEA n = 40

Difference [95% CI]

Statistical value

p value

MPCIA vs OPCIA

MPCIA vs PCEA

OPCIA vs PCEA

Gender, n(%)

Male

387 (60.5%)

335 (60.7%)

28 (58.3%)

24 (60.0%)

   

0.149

0.953

Female

253 (39.5%)

217 (39.3%)

20 (41.7%)

16 (40.0%)

Age, year-old, M ± Std (Min-Max)

58.2 ± 12.1 (19.0–84.0)

58.3 ± 12.3 (19.0–84.0)

58.7 ± 10.4 (28.0–79.0)

57.0 ± 11.2 (34.0–78.0)

− 0.44 [−4.82,3.94]

1.26 [−3.51,6.03)

1.70 [−4.53,7.94)

0.244

0.784

Age cohorts, n(%)

≧ 60 years

318 (49.7%)

276 (50.0%)

23 (47.9%)

19 (47.5%)

   

0.177

0.926

≧ 65 years

231 (36.1%)

198 (35.9%)

18 (37.5%)

15 (37.5%)

   

0.141

0.951

≧ 70 years

122 (19.1%)

113 (20.5%)

6 (12.5%)

3 (7.5%)

   

5.461

0.062

≧ 75 years

42 (6.6%)

39 (7.1%)

2 (4.2%)

1 (2.5%)

   

1.086

0.638

Height, cm, M ± Std (Min-Max)

162.2 ± 7.9 (122.0–185.0)

162.5 ± 8.0 (122.0–185.0)

162.2 ± 7.7 (145.0–176.0)

163.3 ± 7.2 (145.0–176.0)

0.33 [−2.81,3.46]

-0.79 [-4.00,2.42]

-1.11 [-5.44,3.21]

0.217

0.805

Weight, kg, M ± Std (Min-Max)

60.8 ± 9.9 (39.0–94.0)

60.9 ± 10.0 (39.0–94.0)

58.6 ± 9.6 (41.0–86.0)

62.0 ± 8.6 (45.0–80.0)

2.26 [-1.31,5.84]

-1.14 [-5.03,2.75]

-3.40 [-8.49,1.69]

1.485

0.227

BMI, kg/m2, M ± Std (Min-Max)

22.9 ± 3.1 (15.6–39.0)

23.0 ± 3.2 (15.6–39.0)

21.9 ± 2.7 (17.1–27.8)

23.2 ± 2.8 (17.2–27.9)

1.13 [-0.10,2.36]

-0.20 [-1.47,1.06]

-1.33 [-3.03,0.37]

2.571

0.077

BMI cohorts (a), n(%)

Normal

330 (57.5%)

284 (57.3%)

25 (62.5%)

21 (55.3%)

   

11.234

0.061

Underweight

43 (7.5%)

34 (6.9%)

7 (17.5%)

2 (5.3%)

   

Overweight

172 (30.0%)

149 (30.0%)

8 (20.0%)

15 (39.5%)

   

Obese

29 (5.1%)

29 (5.8%)

0 (0.0%)

0 (0.0%)

   

Tumor location (b), n(%)

Top

267 (41.7%)

226 (40.9%)

24 (50.0%)

17 (42.5%)

   

3.153

0.533

Middle

109 (17.0%)

99 (17.9%)

6 (12.5%)

4 (10.0%)

   

Bottom

264 (41.3%)

227 (41.1%)

18 (37.5%)

19 (47.5%)

   

Time of operation, h, M ± Std

2.9 ± 1.2

2.9 ± 1.2

3.1 ± 1.3

2.7 ± 1.1

-0.23 [-0.66,0.20]

0.13 [-0.34,0.61]

0.36 [-0.25,0.98]

1.155

0.316

  1. Abbreviation: n = number, M = Mean, Std = Standard deviation, Min = Minimum value, Max = Maximum value, BMI = Body mass index
  2. BMI cohorts (a): Normal: 18.5–23.9 kg/m2, Underweight: less than 18.5 kg/m2, Overweight: 24.0–27.9 kg/m2,Obese: more than 27.9 kg/m2
  3. Tumor location (b): Top: located in and above the duodenum, as in gastric cancer; Middle: located between the duodenum and sigmoid colon, such as transverse colon cancer; Bottom: located at and below the sigmoid colon, such as rectal cancer
Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us